KYMR
Kymera Therapeutics, Inc.Company with tickers: KYMR
CIK
1815442
CUSIP
501575104
Shares Outstanding
82,257,588
Website
https://www.kymeratx.com
13F Activity (30d)
59 filings
59 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jeremy Chadwick | Chief Operating Officer | Retired | 2026-06-08 |